|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | |
| A61P 3/06 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61K 31/22 | |||
| A61K 31/366 | |||
| A61K 31/40 | |||
| A61K 31/405 | |||
| A61K 31/44 | |||
| A61K 31/505 | |||
| A61K 31/66 | |||
| A61K 31/47 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2641917 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13151352.5 |
| Europos patento paraiškos padavimo data | 2008-08-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 86133 P | 2008-08-04 | US |
| (72) |
Jackson, Simon Mark, US
Walker, Nigel Pelham Clinton, US
Piper, Derek Evan, US
Shan, Bei, US
Shen, Wenyan, US
Chan, Joyce Chi Yee, US
King, Chadwick Terence, CA
Ketchem, Randal Robert, US
Mehlin, Christopher, US
Carabeo, Teresa Arazas, US
Cao, Qiong, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |